Tumor bed control with balloon-based accelerated partial breast irradiation: Incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite® Registry Trial

Annals of Surgical Oncology

Volumn 19, Issue 10, 2012, Pages 3165-3170

  Beitsch, Peter D ^a   Wilkinson, J Ben ^b   Vicini, Frank A ^c   Haffty, Bruce ^d   Fine, Richard ^e   Whitworth, Pat ^f   Kuerer, Henry ^g   Zannis, Victor ^h   Lyden, Maureen ⁱ  

^a Dallas Breast Center   (United States)

^b OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^c 21ST CENTURY ONCOLOGY   (United States)

^d ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

^e Advanced Breast Care of Georgia ^*  (United States)

^f Nashville Breast Center   (United States)

^g Breast Care Center of the Southwest   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁱ BioStat International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; ADULT; ARTICLE; BALLOON CATHETER; BREAST CANCER; BREAST CARCINOMA; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR VOLUME;

BRACHYTHERAPY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CATHETERIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTORS, ESTROGEN; REGISTRIES; SURVIVAL RATE;

EID: 84868194899     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2489-x     Document Type: Article

References (28)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-41. (Pubitemid 35176242)
2. Van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143-50.
3. Smith TE, Daesung Lee, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys. 2000;48:1281-9.
4. Seynaeve C, Verhoog LC, van de Bosch LMC, et al. Ipsilateral breast tumor recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer. 2004;40:1150-8. (Pubitemid 38526333)
5. Krauss DJ, Kestin LL, Mitchell CK, et al. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications. Int J Radiat Oncol Biol Phys. 2004;60: 731-40. (Pubitemid 39311752)
6. Gage I, Recht A, Gelman R, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33: 245-51.
7. Kurtz JM, Amalric R, Brandone H. Local recurrence after breastconserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 1989;63:1912-7. (Pubitemid 19118888)
8. Recht A, Silver B, Schnitt S, et al. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys. 1985;11: 1271-6. (Pubitemid 15067909)
9. Kurtz JM, Spitalier JM, Amalric R, et al. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 1990;18:87-93. (Pubitemid 20047395)
10. Yi M, Buchholz TA, Meric-Bernstam F, et al. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg. 2011;253:572-9.
11. Antonucci JV, Wallace M, Goldstein NS, et al. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys. 2009;74:447-52.
12. Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results from a randomized trial. Int J Radiat Oncol Biol Phys. 2007;69:694-702. (Pubitemid 47418409)
13. Swanson TA, Vicini FA. Overview of accelerated partial breast irradiation. Curr Oncol Rep. 2008;10:54-60.
14. Vicini F, Beitsch PD, Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons Mammo Site Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer. 2008;112:758-66. (Pubitemid 351240569)
15. Chao KK, Vicini FA, Wallace M, et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial breast irradiation: the William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys. 2007;69:32-40. (Pubitemid 47247500)
16. Stewart AJ, O'Farrell DA, Cormack RA, et al. Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. Radiat Oncol. 2008;3:39.
17. Biagioli MC, Harris EE. Accelerated partial breast irradiation: potential roles following breast-conserving surgery. Cancer Control. 2010;17:191-204.
18. Kennedy T, Stewart AK, Bilimoria KY, et al. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients. Ann Surg Oncol. 2007;14:2918-27. (Pubitemid 47460628)
19. Vicini FA, Beitsch PD, Quiet CA, et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer. 2005;104: 1138-48. (Pubitemid 41278948)
20. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289-93. (Pubitemid 36069086)
21. Arthur D, Vicini FA, Kuske RR, et al. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy. 2003;2:124-130. (Pubitemid 36960130)
22. Husain ZA, Mahmood U, Hanlon A, et al. Accelerated partial breast irradiation via brachytherapy: a patterns-of-care analysis with ASTRO consensus statement groupings. Brachytherapy. 2011;10:479-85.
23. Aburabia M, Roses RE, Kuerer HM, et al. Axillary failure in patients treated with MammoSite accelerated partial breast irradiation. Ann Surg Oncol. 2011;18:3415-21.
24. Shah C, Antonucci JV, Wilkinson JB, et al. Twelve-year outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matchedpair analysis. Radiother Oncol. 2011;100:210-4.
25. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007;25:3259-65. (Pubitemid 47325610)
26. Huang E, Buchholz TA, Meric F, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology. Cancer. 2002;95:2059-67.
27. Komoike Y, Akiyama F, Lino Y, et al. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer. 2005;12:104-11.
28. Abd-A lla HM, Lotayef MM, Bakr AA, et al. Ipsilateral in-breast tumor relapse after breast conservation therapy: true recurrence versus new primary. J Egyptian Natl Cancer Inst. 2006;18: 183-90.